BCL2 and breast carcinoma: The compound has been reported to trigger apoptosis via the mitochondrial apoptotic pathway in various cancer types, such as breast cancer, gastric carcinoma, and hepatic cancer, by optimizing the Bcl-2/Bax ratio to activate the caspase cascade [46].